These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28190374)

  • 1. The use of Quality-Adjusted Life Years in cost-effectiveness analyses in palliative care: Mapping the debate through an integrative review.
    Wichmann AB; Adang EM; Stalmeier PF; Kristanti S; Van den Block L; Vernooij-Dassen MJ; Engels Y;
    Palliat Med; 2017 Apr; 31(4):306-322. PubMed ID: 28190374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QALY-time: experts' view on the use of the quality-adjusted LIFE year in COST-effectiveness analysis in palliative care.
    Wichmann AB; Goltstein LCMJ; Obihara NJ; Berendsen MR; Van Houdenhoven M; Morrison RS; Johnston BM; Engels Y;
    BMC Health Serv Res; 2020 Jul; 20(1):659. PubMed ID: 32678021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness and cost-effectiveness of hospital-based specialist palliative care for adults with advanced illness and their caregivers.
    Bajwah S; Oluyase AO; Yi D; Gao W; Evans CJ; Grande G; Todd C; Costantini M; Murtagh FE; Higginson IJ
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012780. PubMed ID: 32996586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic Evaluation of Palliative Care Interventions: A Review of the Evolution of Methods From 2011 to 2019.
    Parackal A; Ramamoorthi K; Tarride JE
    Am J Hosp Palliat Care; 2022 Jan; 39(1):108-122. PubMed ID: 34024147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What cost components are relevant for economic evaluations of palliative care, and what approaches are used to measure these costs? A systematic review.
    Gardiner C; Ingleton C; Ryan T; Ward S; Gott M
    Palliat Med; 2017 Apr; 31(4):323-337. PubMed ID: 27670418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliative care for the terminally ill in America: the consideration of QALYs, costs, and ethical issues.
    Yang YT; Mahon MM
    Med Health Care Philos; 2012 Nov; 15(4):411-6. PubMed ID: 22071573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using qualitative methods to inform the trade-off between content validity and consistency in utility assessment: the example of type 2 diabetes and Alzheimer's disease.
    McGrath C; Rofail D; Gargon E; Abetz L
    Health Qual Life Outcomes; 2010 Feb; 8():23. PubMed ID: 20152041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-utility analysis and quality adjusted life years.
    Joish VN; Oderda GM
    J Pain Palliat Care Pharmacother; 2005; 19(1):57-61. PubMed ID: 15814516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost-effectiveness study of person-centered integrated heart failure and palliative home care: Based on a randomized controlled trial.
    Sahlen KG; Boman K; Brännström M
    Palliat Med; 2016 Mar; 30(3):296-302. PubMed ID: 26603186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for a systematic review of preference-based instruments for measuring care-related outcomes and their suitability for the palliative care setting.
    McCaffrey N; Al-Janabi H; Currow D; Hoefman R; Ratcliffe J
    BMJ Open; 2016 Sep; 6(9):e012181. PubMed ID: 27619829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness and palliative care.
    Bruner DW
    Semin Oncol Nurs; 1998 May; 14(2):164-7. PubMed ID: 9580941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods.
    Hernández Alava M; Wailoo A; Pudney S; Gray L; Manca A
    Health Technol Assess; 2020 Jun; 24(34):1-68. PubMed ID: 32613941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of a specialist palliative care nurse-patient consultation followed by an interprofessional case conference for patients with non-oncological palliative care needs: results of the KOPAL trial.
    Gottschalk S; König HH; Mallon T; Schulze J; Weber J; Böttcher S; Sekanina U; Asendorf T; Hummers E; Freitag M; Schneider N; Friede T; Nauck F; Scherer M; Marx G; Dams J
    Ann Palliat Med; 2023 Nov; 12(6):1175-1186. PubMed ID: 37872126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-of-Life Care Interventions: An Economic Analysis.
    Pham B; Krahn M
    Ont Health Technol Assess Ser; 2014; 14(18):1-70. PubMed ID: 26339303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palliative care and the QALY problem.
    Hughes J
    Health Care Anal; 2005 Dec; 13(4):289-301. PubMed ID: 16435466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valuing health-related quality of life in heart failure: a systematic review of methods to derive quality-adjusted life years (QALYs) in trial-based cost-utility analyses.
    Rankin J; Rowen D; Howe A; Cleland JGF; Whitty JA
    Heart Fail Rev; 2019 Jul; 24(4):549-563. PubMed ID: 30903357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is a QALY still a QALY at the end of life?
    Round J
    J Health Econ; 2012 May; 31(3):521-7. PubMed ID: 22591713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.